Role of Nod2 in the response of macrophages to toll-like receptor agonists

被引：0
|
作者：
Desreumaux, P [1 ]
Malapel, M [1 ]
机构：
[1] CHRU, Equipe 0114, INSERM, Serv Malad Allareil Digestif & Nutr, Lille, France
来源：
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE | 2003年 / 28卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：319 / 320
页数：2
相关论文
共 50 条
  • [11] Toll-like receptor agonists and cancer
    不详
    NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (07) : 511 - 511
  • [12] Radiotherapy and Toll-Like Receptor Agonists
    Marabelle, Aurelien
    Filatenkov, Alex
    Sagiv-Barfi, Idit
    Kohrt, Holbrook
    SEMINARS IN RADIATION ONCOLOGY, 2015, 25 (01) : 34 - 39
  • [13] NOD2/CARD15, toll-like receptor 4, and toll-like receptor 9 gene polymorphisms, in Spanish and Dutch patients with inflammatory bowel disease
    Sans, Miquel
    Figueroa, Carolina
    Crusius, Bart
    Artieda, Marta
    van Bodegraven, Ad A.
    Van Hogezand, R. A.
    Mendoza, Juan L.
    Rodrigo, Luis
    Barreiro, Manuel
    Arroyo, Maria Teresa
    Tejedor, Diego
    Aceituno, Montserrat
    Taxonera, Carlos
    Alvarez-Lobos, Manuel
    Martinez, Antonio
    Ayala, Edgar
    Simon, Laureano
    Verspaget, Hein W.
    Pena, Amado S.
    Panes, Julian
    GASTROENTEROLOGY, 2008, 134 (04) : A463 - A463
  • [14] NOD2 is a negative regulator of Toll-like receptor 2–mediated T helper type 1 responses
    Tomohiro Watanabe
    Atsushi Kitani
    Peter J Murray
    Warren Strober
    Nature Immunology, 2004, 5 : 800 - 808
  • [15] TNF-α promoter, Nod2 and toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin
    Schippers, EF
    van t' Veer, C
    Van Voorden S
    Martina, CAE
    Le Cessie, S
    Van Dissel, JT
    CYTOKINE, 2004, 26 (01) : 16 - 24
  • [16] Response to Toll-Like Receptor agonists in human neonatal foreskin
    Bonish, B. K.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S127 - S127
  • [17] Toll-like receptors involved in the response to microbial pathogens: Development of agonists for toll-like receptor 9
    Schetter, C
    Vollmer, J
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2004, 7 (02) : 204 - 210
  • [18] The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy
    Huang, Lingling
    Ge, Xiaoyan
    Liu, Yang
    Li, Hui
    Zhang, Zhiyue
    PHARMACEUTICS, 2022, 14 (06)
  • [19] Synergistic effect of Nod1 and Nod2 Agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells
    Tada, H
    Aiba, S
    Shibata, KI
    Ohteki, T
    Takada, H
    INFECTION AND IMMUNITY, 2005, 73 (12) : 7967 - 7976
  • [20] NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis
    Ferwerda, Gerben
    Girardin, Stephen E.
    Kullberg, Bart-Jan
    Le Bourhis, Lionel
    de Jong, Dirk J.
    Langenberg, Dennis M. L.
    van Crevel, Reinout
    Adema, Gosse J.
    Ottenhoff, Tom H. M.
    Van der Meer, Jos W. M.
    Netea, Mihai G.
    PLOS PATHOGENS, 2005, 1 (03) : 279 - 285
12345